Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04950608 · ClinicalTrials.gov registry record · Phase 2

Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care

A Phase 2 study of Cancer-related Problem/Condition and Psychotherapy, sponsored by Yvan Beaussant, MD, MSci.

Completed
Registry status
Phase 2
Development phase
15
Enrollment target
1
Study location

NCT04950608 is a Phase 2 study of Cancer-related Problem/Condition and Psychotherapy that has completed, run by Yvan Beaussant, MD, MSci. The registered enrollment target is 15 participants, below the 112-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04950608, a Phase 2 study of Cancer-related Problem/Condition and Psychotherapy, has completed, sponsored by Yvan Beaussant, MD, MSci.

COMPLETED
Registry status
Phase 2
Development phase
15 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this study is to develop and pilot test a novel regimen of psilocybin-assisted psychotherapy for demoralization in patients receiving hospice care. -The name of the study drug involved in this study is Psilocybin

Conditions Studied

Cancer-related Problem/Condition Psychotherapy Hospice Terminal Illness Demoralization Psilocybin Cancer Terminal Terminal Cancer

Interventions

  • BEHAVIORAL Psychotherapy
  • DRUG Psilocybin

Study Locations (1)

Massachusetts

  • Care Dimensions - Danvers

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2022-03-09
Est. Completion 2025-12-31
Phase Phase 2

Sponsor

Yvan Beaussant, MD, MSci

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04950608

The ClinicalTrials.gov registry entry for NCT04950608 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 112-participant average among 10 other Cancer-related Problem/Condition trials with a reported enrollment target (87% lower). The listed sponsor is Yvan Beaussant, MD, MSci, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Cancer-related Problem/Condition appearing as the primary indexed condition, and to 2 interventions - of which Psychotherapy is the first listed.

NCT04950608 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04950608 about?

NCT04950608 is a clinical study titled "Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care". The overall objective of this study is to develop and pilot test a novel regimen of psilocybin-assisted psychotherapy for demoralization in patients receiving hospice care. -The name of the study drug involved in this study is Psilocybin

What is the current status of trial NCT04950608?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2022-03-09. Estimated completion is 2025-12-31.

What conditions does trial NCT04950608 study?

This clinical trial studies the following conditions: Cancer-related Problem/Condition, Psychotherapy, Hospice, Terminal Illness, Demoralization.

What interventions are being tested in trial NCT04950608?

The interventions under investigation include: Psychotherapy (BEHAVIORAL), Psilocybin (DRUG).

Who is sponsoring clinical trial NCT04950608?

This trial is sponsored by Yvan Beaussant, MD, MSci, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04950608 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer-related Problem/Condition

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer-related Problem/Condition

All registered trials for this condition

Psychotherapy

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.